Platelets and thrombopoiesis: Visualization of nitric oxide production by individual platelets during adhesion in flowing blood

Blood

Volumn 125, Issue 4, 2015, Pages 697-705

  Cozzi, Maria Rita ^a   Guglielmini, Giuseppe ^b   Battiston, Monica ^a   Momi, Stefania ^b   Lombardi, Elisabetta ^a   Miller, Edward Cole ^a   De Zanet, Denise ^a   Mazzucato, Mario ^a   Gresele, Paolo ^b   De Marco, Luigi ^a,c  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 5 METHYLAMINO 2',7' DIFLUOROFLUORESCEIN DIACETATE; ARGININE (NITRIC OXIDE SYNTHASE); CALCIUM ION; COLLAGEN; FLUORESCENT DYE; MEPACRINE; N(G) METHYLARGININE; NITRIC OXIDE; UNCLASSIFIED DRUG; 4-AMINO-5-METHYLAMINO-2',7'-DIFLUOROFLUORESCEIN DIACETATE; CALCIUM; ENZYME INHIBITOR; FLUORESCEIN DERIVATIVE;

ANIMAL CELL; ARTICLE; BLOOD FLOW; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NONHUMAN; PLATELET REACTIVITY; PRIORITY JOURNAL; SHEAR RATE; STEREOISOMERISM; THROMBOCYTE ADHESION; ANIMAL; BLOOD FLOW VELOCITY; CYTOLOGY; DRUG EFFECTS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PLATELETS; CALCIUM; COLLAGEN; ENZYME INHIBITORS; FLUORESCEINS; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PLATELET ADHESIVENESS; QUINACRINE;

EID: 84921629241     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-579474     Document Type: Article

References (58)

1. Schlossmann J, Feil R, Hofmann F. Signaling through NO and cGMP-dependent protein kinases. Ann Med. 2003;35(1):21-27.
2. Reichenbach G, Momi S, Gresele P. Nitric oxide and its antithrombotic action in the cardiovascular system. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5(1):65-74.
3. Raiesdana A, Loscalzo J. Vessel wall-derived substances affecting platelets. In: Gresele P, Fuster V, Lopez JA, Page CP, Vermylen J, eds. Platelets in hematologic and cardiovascular disorders: a clinical handbook. Cambridge, UK: Cambridge University Press; 2008:92-105.
4. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(Pt 3):593-615.
5. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2003;284(1):R1-R12.
6. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med. 1995;125(3):370-377.
7. Wallerath T, Gath I, Aulitzky WE, Pollock JS, Kleinert H, Förstermann U. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost. 1997;77(1):163-167.
8. Sase K, Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57(22):2049-2055.
9. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; 2(8567):1057-1058.
10. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990;87(13):5193-5197.
11. Falcinelli E, Francisci D, Belfiori B, et al. In vivo platelet activation and platelet hyper-reactivity in abacavir-treated HIV-infected patients. Thromb Haemost. 2013;110(2):349-357.
12. Momi S, Caracchini R, Falcinelli E, Evangelista S, Gresele P. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. Arterioscler Thromb Vasc Biol. 2014;34(4): 820-829.
13. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 1997;100(2):350-356.
14. Kanaya S, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation. Circulation. 2001;104(20):2478-2484.
15. Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JF Jr, Vita JA. Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation. 1998; 98(15):1481-1486.
16. Malinski T, Radomski MW, Taha Z, Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun. 1993;194(2):960-965.
17. Iafrati MD, Vitseva O, Tanriverdi K, et al. Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. Am J Physiol Heart Circ Physiol. 2005;288(4):H1627-H1632.
18. Ozüuyaman B, Gödecke A, Küsters S, Kirchhoff E, Scharf RE, Schrader J. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thromb Haemost. 2005; 93(6):1161-1167.
19. Marjanovic JA, Li Z, Stojanovic A, Du X. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation. J Biol Chem. 2005;280(45):37430-37438.
20. Gambaryan S, Kobsar A, Hartmann S, et al. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost. 2008;6(8):1376-1384.
21. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. BMJ. 1994;309(6952):453-457.
22. Hetrick EM, Schoenfisch MH. Analytical chemistry of nitric oxide. Annu Rev Anal Chem (Palo Alto Calif). 2009;2:409-433.
23. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest. 1996;56(7):577-581.
24. Cortese-Krott MM, Rodriguez-Mateos A, Sansone R, et al. Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. Blood. 2012;120(20):4229-4237.
25. Gresele P, Blockmans D, Deckmyn H, Vermylen J. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. J Pharmacol Exp Ther. 1988;246(1):301-307.
26. Merritt JE, McCarthy SA, Davies MP, Moores KE. Use of fluo-3 to measure cytosolic Ca21 in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca21. Biochem J. 1990;269(2):513-519.
27. Mazzucato M, Pradella P, Cozzi MR, De Marco L, Ruggeri ZM. Sequential cytoplasmic calcium signals in a 2-stage platelet activation process induced by the glycoprotein Ibalpha mechanoreceptor. Blood. 2002;100(8): 2793-2800.
28. Momi S, Falcinelli E, Giannini S, et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med. 2009; 206(11):2365-2379.
29. Folie BJ, McIntire LV, Lasslo A. Effects of a novel antiplatelet agent in mural thrombogenesis on collagen-coated glass. Blood. 1988;72(4):1393-1400.
30. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657-666.
31. Usami S, Chen HH, Zhao Y, Chien S, Skalak R. Design and construction of a linear shear stress flow chamber. Ann Biomed Eng. 1993;21(1):77-83.
32. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem. 1986;261(27):12579-12585.
33. Momi S, Monopoli A, Alberti PF, et al. Nitric oxide enahnces the anti-inflammatory and antiatherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. Cardiovasc. Res. 2012;94(3):428-438.
34. Mazzucato M, Cozzi MR, Battiston M, et al. Distinct spatio-temporal Ca21 signaling elicited by integrin alpha2beta1 and glycoprotein VI under flow. Blood. 2009;114(13):2793-2801.
35. Tymvios C, Moore C, Jones S, Solomon A, Sanz-Rosa D, Emerson M. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol. 2009; 158(7):1735-1742.
36. Jourd'heuil D. Increased nitric oxide-dependent nitrosylation of 4,5-diaminofluorescein by oxidants: implications for the measurement of intracellular nitric oxide. Free Radic Biol Med. 2002;33(5):676-684.
37. Gresele P, Momi S, Falcinelli E. Anti-platelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol. 2011;72(4):634-646.
38. Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A. beta(2)-adrenoceptors activate nitric oxide synthase in human platelets. Circ Res. 2000; 87(1):39-44.
39. Freedman JE, Sauter R, Battinelli EM, et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res. 1999;84(12):1416-1421.
40. Li Z, Xi X, Gu M, et al. A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell. 2003;112(1):77-86.
41. Apostoli GL, Solomon A, Smallwood MJ, Winyard PG, Emerson M. Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo. J Thromb Haemost. 2014;12(11):1880-1889.
42. Trebak M, Ginnan R, Singer HA, Jourd'heuil D. Interplay between calcium and reactive oxygen/ nitrogen species: an essential paradigm for vascular smooth muscle signaling. Antioxid Redox Signal. 2010;12(5):657-674.
43. Kanai AJ, Strauss HC, Truskey GA, Crews AL, Grunfeld S, Malinski T. Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ Res. 1995; 77(2):284-293.
44. Deliu E, Brailoiu GC, Mallilankaraman K, et al. Intracellular endothelin type B receptor-driven Ca21 signal elicits nitric oxide production in endothelial cells. J Biol Chem. 2012;287(49): 41023-41031.
45. Blatter LA, Taha Z, Mesaros S, Shacklock PS, Wier WG, Malinski T. Simultaneous measurements of Ca21 and nitric oxide in bradykinin-stimulated vascular endothelial cells. Circ Res. 1995;76(5):922-924.
46. Lantoine F, Iouzalen L, Devynck MA, Millanvoye-Van Brussel E, David-Dufilho M. Nitric oxide production in human endothelial cells stimulated by histamine requires Ca21 influx. Biochem J. 1998;330(Pt 2):695-699.
47. Berkels R, Dachs C, Roesen R, Klaus W. Simultaneous measurement of intracellular Ca(2+) and nitric oxide: a new method. Cell Calcium. 2000;27(5):281-286.
48. Gkaliagkousi E, Douma S, Zamboulis C, Ferro A. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J Hypertens. 2009;27(12):2310-2320.
49. Jin RC, Loscalzo J. Vascular Nitric Oxide: Formation and Function. J Blood Med. 2010; 2010(1):147-162.
50. Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res. 2007;101(7):654-662.
51. Gardiner EE, Arthur JF, Berndt MC, Andrews RK. Role of calmodulin in platelet receptor function. Curr Med Chem Cardiovasc Hematol Agents. 2005;3(4):283-287.
52. Kerry R, Scrutton MC. Platelet betaadrenoceptors. Br J Pharmacol. 1983;79(3): 681-691.
53. Moore C, Tymvios C, Emerson M. Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase. Thromb Haemost. 2010;104(2): 342-349.
54. Ichiki K, Ikeda H, Haramaki N, Ueno T, Imaizumi T. Long-term smoking impairs platelet-derived nitric oxide release. Circulation. 1996;94(12):3109-3114.
55. Ikeda H, Takajo Y, Murohara T, et al. Platelet-derived nitric oxide and coronary risk factors. Hypertension. 2000;35(4):904-907.
56. Erdmann J, Stark K, Esslinger UB, et al CARDIoGRAM. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature. 2013;504(7480):432-436.
57. Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke. 2000;31(10): 2442-2449.
58. Tannous M, Cheung R, Vignini A, Mutus B. Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects. Thromb Haemost. 1999;82(5):1390-1394.